- Home
- UAMY vs ZTEK Comparison
UAMY vs ZTEK Comparison
Compare UAMY & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UAMY | ZTEK |
|---|---|---|
| Founded | 1968 | 2008 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Major Chemicals |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 829.0M | 89.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | UAMY | ZTEK |
|---|---|---|
| Price | $4.84 | $0.67 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $5.69 | N/A |
| AVG Volume (30 Days) | ★ 8.3M | 42.6K |
| Earning Date | 11-12-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $31,857,819.00 | $657,134.00 |
| Revenue This Year | $159.13 | N/A |
| Revenue Next Year | $228.42 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 177.97 | ★ 2225.73 |
| 52 Week Low | $1.21 | $0.62 |
| 52 Week High | $19.71 | $1.84 |
Technical Indicators
Market Signals| Indicator | UAMY | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 34.56 | 35.05 |
| Support Level | $5.16 | $0.70 |
| Resistance Level | $6.95 | $0.75 |
| Average True Range (ATR) | 0.51 | 0.04 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 3.66 | 5.63 |
Price Performance
Historical ComparisonAbout UAMY United States Antimony Corporation
United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has two operating segments: antimony and zeolite. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.